Crispr in Animals and Animal Models
92,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
46 °P sammeln
  • Gebundenes Buch

CRISPR in Animals and Animal Models, Volume 152, the latest release in the Progress in Molecular Biology and Translational Science series, explores the genome editing CRISPR system in cells and animal models, its applications, the uses of the CRISPR system, and the past, present and future of CRISPR genome editing. Topics of interest in this updated volume include a section on CRISPR history, The genome editing revolution, Programming CRISPR and its applications, CRISPR Delivery methods, CRISPR libraries and screening, CRISPR investigation in haploid cells, CRISPR in the generation of…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
CRISPR in Animals and Animal Models, Volume 152, the latest release in the Progress in Molecular Biology and Translational Science series, explores the genome editing CRISPR system in cells and animal models, its applications, the uses of the CRISPR system, and the past, present and future of CRISPR genome editing. Topics of interest in this updated volume include a section on CRISPR history, The genome editing revolution, Programming CRISPR and its applications, CRISPR Delivery methods, CRISPR libraries and screening, CRISPR investigation in haploid cells, CRISPR in the generation of transgenic animals, CRISPR therapeutics, and Promising strategies and present challenges.
Autorenporträt
Raúl Torres-Ruiz graduated in Biological Sciences (2004) and obtained his PhD in Molecular Biology (2013) for his studies related to genome engineering and viral vectors. His research work is based on the development of Genome Engineering novel technologies. This new technologies are characterized by a high potential in the study of causes and mechanisms involved in the development of human diseases. He has implemented the CRISPR-Cas9 system to reproduce chromosomal rearrangements characteristics of human neoplasias. One of the main objectives of our group was the development of methods and tools for human cell gene editing with therapeutic purposes and to model human illnesses. During this time, I have also work in the generation of novel systems for virus delivery (AAV, Adenovirus y Lentivirus) improving their potential as tools for basic and applied experimentation. In fact, one of those systems has been translated in a patent license.
Rezensionen
Praise for the Series:
"Maintains the tradition and set-up of the previous volumes and certainly provides up-to-date data on varied aspects of cytology... a valuable acquisition to any library." --The Nucleus